IL-17 vs. IL-23: The Latest Comparison
Dr. April Armstrong discusses key benefits and newer developments in IL-17 and IL-23 inhibitors for the treatment of moderate to severe plaque psoriasis. April Armstrong, MD, is Professor of Dermatology, University of Southern California Keck School of Medicine, Los Angeles, California “At the Winter Clinical, we oftentimes do a deep dive into the different biologics. For […]